Sandra Camelo-Piragua, MD recognized for her expertise by the American Board of Pathology

By Lynn McCain | June 12 2023

Camelo-Piragua, Sandra  (500 × 500 px).jpgThe American Board of Pathology announced today that our own Dr. Sandra Camelo-Piragua, Professor of Neuropathology and Director of the Neuropathology Fellowship Program, has been selected to serve on the Test Development and Advisory Committee for Neuropathology - a testament to her expertise in the field. The full text of the press release is below.  Please join me in congratulating Dr. Camelo-Piragua!



The American Board of Pathology Announces the Appointment of Sandra Camelo-Piragua, M.D. 

to the Test Development and Advisory Committee for Neuropathology


TAMPA, Fla., (6/9/2023) The American Board of Pathology (ABPath) is pleased to announce the appointment of Sandra Camelo-Piragua, M.D to the ABPath’s Test Development and Advisory Committee (TDAC) for Neuropathology beginning in 2024. The TDACs are responsible for developing and reviewing the ABPath certification exam questions that assess and certify a physician’s education, knowledge, experience, and skills in order to provide high-quality care in the pathology profession.

To be appointed to a TDAC means a physician is an established subject matter expert in their subspecialty field and is current on the latest advances in the continually evolving field of pathology and patient care. TDAC committee members develop and review examination questions for statistical performance and relevance to current practice. They contribute to the validity of examinations by determining the content and distribution of items on examinations (exam blueprints).  The TDACs also advise the ABPath on issues in their subspecialty area of expertise. 

“The members of our Test Development and Advisory committees are experts in their respective fields.  These individuals are instrumental in assessment development, the setting of standards, and provide guidance regarding the current state of Pathology.  The appointment of an individual to a test committee is a recognition of their expertise and their contributions ensures the integrity and relevance of board certification,” states Gary W. Procop, MD, CEO of the American Board of Pathology.


Since 1971, the ABPath has appointed test committees for each specialty area of pathology. The committee consists of ABPath trustees and other pathologists or specialty physicians who are recognized experts in their respective disciplines. There are presently 14 ABPath TDACs.  They are: Anatomic Pathology, Anatomic Pathology CertLink®, Blood Banking/Transfusion Medicine, Chemical Pathology, Clinical Pathology CertLink®, Management and Informatics, Cytopathology, Dermatopathology (with appointees from the American Board of Dermatology), Forensic Pathology, Hematopathology, Medical Microbiology, Molecular Genetic Pathology (with appointees from the American Board of Medical Genetics and Genomics), Neuropathology, and Pediatric Pathology.


About the American Board of Pathology

The mission of the American Board of Pathology, as a member of the American Board of Medical Specialties, is to serve the public and advance the profession of pathology by setting certification standards and promoting lifelong competency of pathologists. Founded in 1936, the ABPath accomplishes this mission by establishing certification and continuing certification standards and assessing the qualifications of those seeking to obtain voluntary certification in the specialty of pathology.  For more information on ABPath, visit or call (813) 286-2444.